Eden Innovations Accelerates US Expansion and Launches Defence Division Amid Debt Elimination

Rapid EdenCrete Rollout in North America

Eden Innovations Ltd (ASX:EDE) has significantly expanded its EdenCrete Pz7 concrete additive footprint in the US, with Amrize requesting installations of bulk storage tanks and dispensing equipment at five additional ready-mix concrete plants in Colorado. This brings the total Amrize plants using EdenCrete Pz7 to 10 out of their 300-plant network, highlighting substantial room for further growth across North America. Alongside this, Eden completed installations at two Quikrete plants and is preparing for two more within the US-wide Quikrete group, marking a major new channel for EdenCrete’s market penetration. Management anticipates a sharp increase in EdenCrete Pz7 sales over the next 12 to 24 months as these networks mature. This momentum builds on the company’s earlier success supplying Holcim Ecuador, where cumulative sales have surpassed US$697,830, with recent orders nearly doubling prior purchases. Eden’s international trials continue across Canada, Mexico, the UK, France, and India, with the latter’s Concrete Road Repair Institute commencing new trials this April after delays unrelated to Eden’s technology. The company remains optimistic about Indian market penetration following these critical tests. These developments echo the company’s recent expansion to 29 ready-mix concrete plants across the Americas, underscoring Eden’s growing footprint in sustainable construction materials.

EdenShield Division Targets Defence and Infrastructure

In response to rising global geopolitical tensions and heightened government focus on infrastructure resilience, Eden launched EdenShield®, a dedicated division to commercialise its carbon nanotube (CNT) enhanced materials and dual-fuel technologies for defence, military, and critical infrastructure markets. EdenShield® will market EdenCrete® ultra-high performance concrete with blast resistance and electromagnetic shielding, alongside OptiBlend®, a dual-fuel system that extends diesel generator runtime by up to 150% while cutting fuel costs. The division aims to secure pilot projects and contracts across strategic assets such as data centres, ports, airports, and military installations. Future development pipelines include lightweight polymers for UAV applications and radiation-absorbent materials for aerospace. This strategic move aligns with Eden’s prior announcement of EdenShield’s market focus and advisory appointments in the defence sector, reflecting a concerted push into high-growth, high-security infrastructure markets. Eden’s technologies offer practical mitigation against blast damage, EMP events, and thermal stress, although they cannot eliminate such risks entirely. The launch follows the company’s recent EdenShield launch targeting defence sectors and signals an ambitious diversification beyond construction materials.

OptiBlend Sales Surge with US Data Centres

Eden’s OptiBlend dual-fuel technology is gaining traction among US data centres, driven by the sector’s demand for cost-effective, lower-emission backup power solutions. The active US quotations pipeline stands at approximately US$4.33 million (A$6.0 million), supported by confirmed purchase orders of US$456,000. OptiBlend revenue in the first nine months of FY2026 exceeded US$1.18 million, marking a 65% increase over the full FY2025 sales. This growth is underpinned by OptiBlend’s ability to extend generator runtime and reduce emissions without engine modifications, a compelling proposition for critical infrastructure operators. Eden’s focus on AI and cloud data centre applications is further supported by new R&D investments targeting enhanced heat dissipation and electromagnetic shielding properties of CNT concrete. These initiatives build on the company’s established presence in the data centre market and its proprietary carbon nanotube production capabilities, positioning Eden to capitalise on an expected US$1 trillion global data centre investment pipeline by 2035. This momentum reflects the company’s earlier US OptiBlend revenue growth of 65 percent and its strategic R&D expansion into AI data centre infrastructure.

Financial Restructuring Strengthens Balance Sheet

Eden Innovations has completed a significant debt reduction milestone by fully repaying its high-cost iBorrow loan facility of A$8.7 million, which previously imposed over A$1 million annually in interest and servicing costs. This was achieved through a strategic A$2.2 million convertible note investment from 7 Enterprises Pty Ltd, which converted to shares, increasing the investor’s stake to 6.1%. Further agreements are in place to settle outstanding loans and accrued director fees totaling approximately A$1.84 million via share issues, pending shareholder approval. These moves materially improve Eden’s cash flow profile and reduce financial risk ahead of its next growth phase. Post-quarter, Eden completed an institutionally led placement raising A$4.05 million at $0.18 per share, a 41% premium to the 15-day VWAP, anchored by L1 Capital Global Opportunities Master Fund and managed by Oakley Capital Partners and Bell Potter Securities. At quarter-end, cash reserves stood at A$2.57 million, with approximately 237 million in-the-money options potentially providing a further A$20.46 million if exercised. This recapitalisation follows Eden’s earlier half-year profit and debt reduction and sets a solid foundation for scaling commercial operations.

Leadership and Growth Outlook

The appointment of Dr Allan Godsk Larsen as Managing Director signals Eden’s commitment to accelerating global growth. Dr Larsen, previously Chief Scientist and inventor of EdenCretePz and Pz7 products, brings deep technical expertise and commercial insight. The company is also considering further key hires to bolster its business development capabilities. Eden continues to market its freehold property in Littleton, Colorado, appraised at US$2.6 million, which could provide additional working capital upon sale. Looking ahead, Eden’s priorities include scaling EdenCrete Pz7 sales across major ready-mix networks in the Americas, advancing EdenShield commercialisation and next-gen CNT materials, expanding OptiBlend penetration in US data centres, progressing international trials, and driving R&D for AI and cloud data centre applications. The company aims to reach positive operating cash flow in the near term, leveraging its de-risked balance sheet and strengthened management team.